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Macrophages are “first responders”, innate immune system cells which quickly arrive to a 
site of infection and injury, consuming cell debris and foreign matter and recruiting other 
immune system cells to the area. While historically they have been thought to react uniformly to 
all challenges, the discovery of toll-like receptors has shown that macrophages actually work 
closely with the adaptive immune system in fine-tuning the immune response. Furthermore, it 
has recently been discovered that macrophages can become polarized to one of two subtypes – 
M1 or M2.  
M1 macrophages are efficient producers of reactive oxygen species, nitrogen 
intermediates, and inflammatory cytokines. They are especially effective at mediating 
resistance against intracellular parasites and tumors. Arginine metabolism in M1 
macrophages is characterized by high levels of inducible nitric oxide synthetase (iNos), 
and this is used as a marker for polarization of macrophages to the M1 phenotype.  M2 
macrophages, by contrast, produce anti-inflammatory molecules, have high levels of 
scavenger, mannose, and galactose-type receptors, and arginine metabolism is shifted 
to production of ornithine and polyamines via arginase. Arginase, encoded by the ARG1 
gene, is considered to be one of the hallmarks of the M2 phenotype, and is one of the 
most specific markers used to determine polarization to that phenotype.  
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Polarization to one phenotype or another is not permanent, and macrophages can 
be polarized directly from one state to the other directly by addition of appropriate 
cytokines (IFNy, LPS, TNFa for M1, IL-4, IL-13, IL-10, TGFb for M2). The state of 
macrophage polarization can be determined by examining a population of macrophages 
for tell-tale products of one state or another (ROS, RNS, TNFa, IL-1, IL-6, IL-12, or IL-23 
for M1, IL-10, TGFb, PDGF, VEGF, EGF, and arginase for M2). Determining macrophage 
polarization has implications in health outcomes- M1 macrophages excel at fighting 
parasites and fighting tumorous growth, while M2 macrophages assist in wound healing 
and nerve re-growth. The problem is that the methods of detecting macrophage 
polarization – flow cytometry, western blots, or ELISA tests, are not real time and kill the 
cells involved. This paper describes the theory and methods behind creating a plasmid 
which combines the promoter for genes whose transcription indicates the M1 or M2 
phenotype with a GFP or RFP, when transfected into a colony of RAW macrophages, will 
enable realtime, quantitative visualization of the production of inducible nitric oxide 
synthetase or arginase, markers for the M1 and M2 phenotype. A clearer understanding 
of macrophage polarity in the course of illness, wounding, and cancer might lead to 
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INTRODUCTION AND PURPOSE 
Traditionally, macrophages have been thought of as “first responders”, members 
of the innate immune system that serve the body both by engulfing and processing 
foreign threats when possible, and by helping to direct the rest of the immune system in 
combatting threats (Gordon, 1999). One way the macrophage helps direct the immune 
system is by secreting pro-inflammatory and antimicrobial mediators. It is known that, 
through toll-like receptors, macrophages can be made to secrete cytokines that  induce or 
repress inflammation, recruit other immune system cells, and prime elements of the 
adaptive immune response for a fine-tuned response (Stein et al., 1992).  
 
Fig. 1: Macrophages have an important role in the immune system – they modify and direct both the innate and 
adaptive immune system, through antigen presentation and TLRs. Adapted from Scott-Algara et al., 2008 
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Nevertheless, it was previously thought that macrophages existed as essentially single-
phenotype antigen-presenting cells which played a role in the development of the 
immune response through the secretion of various cytokines (Gordon, 1999). 
Today, these macrophages are known to be “classically activated”, or M1 
macrophages. In order to become classically activated, macrophages require priming with 
interferon gamma (IFN- γ) (Dalton, 1993), by way of the IFN-γ receptor (Huang, 1993), 
or through lipopolysaccharide (LPS). When a macrophage thus primed by IFN-γ or LPS 
encounters a recognized stimulus, for example a bacterial product, it initiates classical 
activation. If the macrophage encounters LPS, the LPS is bound by soluble 
lipopolysaccharide-binding protein (LBP) and then by CD14, which can be either soluble 
or membrane-bound. CD14 delivers LPS to the LPS recognition complex (Janeway and 
Medzhitov, 2002), TLR4 and MD-2. (Nagai et al., 2002) The foreign pathogens and their 
components are subsequently taken up by phagocytosis (Greenberg and Grinstein, 2002). 
Once inside the macrophage, they are delivered to lysosomes where they are degraded by 
a variety of enzymes, such as cathepsin cysteine proteases. (Honey and Rudensky, 2003). 
Once degraded by enzymes, the antigens are processed and loaded onto MHC class II 
molecules. On the surface of the macrophage, late endocytic compartments and 
antigen/MHC class II complexes are presented to T cells, along with co-stimulatory B7 




Fig. 2: Antigen presenting cells, like macrophages, serve a vital role in stimulating the proliferation of T cells, here 
shown presenting their antigens to T cells along with costimulatory B7 molecules. Adapted from Zou and Chen, 2008 
Once classically activated, the macrophage undergoes significant changes in its 
morphology and in the content of molecules secreted from the cell. To attract neutrophils 
and limit angiogenesis, C-X-C- Motif protein 8 (CXCL8) is released. CXCL10, 
Chemokine (C-C-motif) ligand 3 (CCL3), and CCL4, chemoattractants for 
polymorphonuclear leukocyotes and natural killer cells, and CCL5, a chemokine for T-
cells, eosinophils, and basophils, are also produced, (Luster, 2002) along with cytokines 
designed to promote inflammation, such as IL-1 β/IL-1F2, IL-6, and TNF-α/TNFSF1A. 
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(Duffield, 2003, Gordan, 2003, Ma et al., 2003, Mosser, 2003). In addition to being 
proinflammatory, TNF-α is a prophagocytic agent for the macrophage (Boyle et al., 2003, 
Duffield et al., 2001, Song et al., 2000). Other hallmarks of classical activation are nitric 
oxide release as a result of inducible nitric oxide synthase (iNOS) upregulation (Hesse et 
al., 2001, Thomassen and Karvau, 2001, Duffield et al., 2000, Munder et al., 1998), and 
Fas Ligand/TNFSF6 secretion (Boyle et al., 2003). Proteolytic enzymes are also released 
by the classically activated macrophage; these include MMP (matrix metalloproteinase)-
1, -2, -7, -9, and -12, which degrade extracellular matrix (ECM) components such as 
collagen, elastin, and fibronectin (Chizzolini et al., 2000, Gibbs et al., 1999 (1), Gibbs et 
al., 1999 (2)).  
  
Fig. 3: Elastic, collagen, and Gelatin can all be degraded with the use of MMPs, shown here released by a classically 
activated macrophage. Adapted from Elkington and Friedland, 2006  
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The release of these molecules is both a boon and a potential hazard. They are 
important for the protection of the host, and also help to direct the course of the innate 
and adaptive immune response. However, they also have the potential to cause significant 
damage to the local host environment. These cytokines are designed to cause infiltration 
by other leukocytes, and can do so on a massive scale. These invading leukocytes and the 
classically activated macrophages themselves can flood the area with pro-apoptotic and 
pro-inflammatory factors, and matrix degrading proteases. In this way, M1 macrophages 
can disrupt tissue structure, to the point of causing serious damage. Not only are there the 
obvious short-term negative consequences of this issue destruction, but tissue destruction 
caused by chronic inflammation has been associated with more long-term negative 
effects, including the development of tumors, type 1 autoimmune diseases, and 
glomerulonephritis (Gordon, 2003, Ma et al., 2003, Mosser, 2003). 
  
Fig. 4: Macrophage accumulation is a prominent feature in most types of human glomerulonephritis: here 
macrophages, stained brown, are shown in the kidney. Adapted from Busey et al., 2012 
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The understanding about macrophage states was broadened in 1993 in the seminal 
paper by Stein, Keshav, Harris, and Gordon. This paper was the first to describe 
macrophages having a phenotype different from the “classically” activated macrophage. 
They noted that when stimulated with IL4, macrophages would display relatively few 
characteristics commonly found in classically activated cells (up-regulation of 
proinflammatory cytokines, recruitment of other immune system cells to the area), but 
did display the upregulation of the macrophage mannose receptor (MRC1), otherwise 
known as CD206, as measured by the binding and degradation of I-mannose-bovine 
serum albumin. They performed PCR analysis of cDNA from purified primary 
macrophage populations to confirm that the macrophage mannose receptor, but not 
lysozyme or tumor necrosis factor alpha levels were increased.  
  
Fig. 5: The two types of macrophage polarization can lead to differing health outcomes, as shown here relating to 
inflammation. Adapted from Tidball, 2011   
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Macrophages taken from wild-type mice in vitro or in vivo, would develop this 
alternate activation when a TH2 response was induced by challenge with Schistosoma 
mansoni eggs. However, in a knockdown strain of mice, that was -/- for IL-4R , the 
common α receptor chain for IL-4 and IL-13 (Th2 cytokines), a similar challenge would 
elicit a classically activated or Th1-type response, not the Th2 response. The mannose 
receptor was expressed by granuloma macrophages in WT mice but not in IL-4Ralpha -/- 
mice, as determined by antibody staining (Linehan et al, 2003). This indicates that the 
alternate response was dependent on Th2-type cytokines, as knocking down the receptor 
for Th2 cytokines also stopped expression of the mannose receptor, the then-prototypical 
marker for alternate activation. Later experiments have shown that the patterns of 
activation shown with the Th2-type cytokines are also dependent on the transcription 
factor STAT6, indicating that there were transcriptional changes associated with an 
alternative activation. This was shown when CD4+ T cells transferred from H. polygyrus-
primed mice induced alternatively activated macrophages in wild-type (d,e) but not Stat6-
/- recipients (Anthony et al., 2006). 
These observations have led to the understanding that “alternate activation” is not 
simply a deactivation of macrophages caused by Th2-type cytokines, but is an alternate 
pattern of activation, a different phenotype designed to accomplish separate goals than a 
classically activated macrophage. “Classically activated”, or M1 macrophages display 
characteristics consistent with a Th1-type phenotype, including chronic inflammation, 
recruitment of other immune system cells to the affected area, and tissue damage, 
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whereas “alternatively activated” or M2 macrophages resolve inflammation and facilitate 
wound healing.  
 
Fig. 6: The products of the M1 and M2 phenotypes of macrophages dictates their roles: outputting NO and citrulline 
makes M1 macrophages killers, while M2 macrophages are anti-inflammatory “healers”. Adapted from Sly et al., 2007 
Alternatively activated, or M2 macrophages, are activated differently than M1 
macrophages. For instance, differentiation of alternatively activated macrophages does 
not require any priming. IL-4
 
(Stein et al., 1992) or IL-13 (Doherty et al., 1993) are 
sufficient to cause the differentiation. Once these factors are bound to their receptors, 
fluid-phase pinocytosis of soluble antigen may take place. (Brombacher, 2000, Conner 
and Schmid, 2003, Montaner et al., 1999) The next step is somewhat like the classical 
activation, wherein soluble antigen is coupled with MHC class II molecules and the 
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antigen/MHCII complexes are subsequently displayed to T cells, along with co-
stimulatory B7 family members. (Harding et al., 2003)  
  
Fig. 7: The process of antigen presentation in macrophages, from uptake and endocytosis to degradation of the invading 
molecule and presentation of the peptide to T cells. The macrophage also releases proinflammatory cytokines.  Adapted 
from Nicchitta, 2003 
Also, similar to the classically activated macrophage, changes are seen in the 
alternatively activated macrophage’s cellular morphology and secreted molecules as a 
result of appropriate stimulation. These macrophages release chemokines which attract 
leukocytes, including pulmonary and activation-regulated chemokine (PARC/CCL18) 
(Kodelja et al., 1998, Goerdt et al., 1999) Macrophage-derived chemokine 
(MDC/CCL22) (Andrew et al., 1998, Imai et al., 1999) and TARC/CCL17. (Imai et al., 
1999) Where the real differences between classical and alternative activation become 
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evident, though is when anti-inflammatory cytokines such as IL-1ra/IL-1F3, (Mantovani 
et al., 2001) Ym1, Ym2, resistin-like molecule A (RELMa), (Raes et al., 2002, Loke et 
al., 2002) IL-10, (Mosser, 2003) and TGF-β are released. In addition to being an anti-
inflammatory mediator, TGF-β also indirectly promotes ECM accumulation by inducing 
nearby fibroblasts to produce ECM components. (Song et al., 2000) ECM accumulation 
is aided by the M2 macrophage itself, which secretes the ECM components Fibronectin 
and bIG-H3, (Gratchev et al., 2001) Trans-glutaminase (a ECM cross-linking enzyme), 
(Haroon et al., 1999) and Osteopontin, which functions by facilitating cell adhesion to the 
ECM. (Murry et al., 1994)  
In addition, alternatively activated macrophages upregulate expression of the 
enzyme Arginase I, which is involved in proline as well as polyamine biosynthesis. 
Proline promotes ECM construction while polyamines are involved in cell 
proliferation.(Hesse et al., 2001) Other factors secreted by the alternatively activated 
macrophage that promote cell proliferation include platelet-derived growth factor 
(PDGF), insulin-like grown factor (IGF), and transforming-growth factor beta (TGF-β). 
(Song et al., 2000, Cao et al., 2000) As well as promoting cell profileration, these factors 
participate in angiogenesis, along with fibroblast growth factor (FGF basic), TGF-α, and 
vascular-endothelial growth factor (VEGF). (Cao et al., 2000, Sunderkotter et al., 1991)  
Taken as a whole, the profile of the molecules secreted by the alternatively 
activated macrophage contribute to an immune response characterized by a lessening of 
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inflammation and promotion of wound repair. The response can be characterized as anti-
inflammatory, proliferative, fibrotic, and angiogenic. In keeping with its profile as similar 
to that of a Th2 reponse, M2 macrophages are also efficient at combating parasitic 
infections, like schistosomiasis and filiariasis. While the alternatively activated 
macrophage is beneficial for the body, and for wound repairing in this way, it is also true 
that M2 macrophages are not as effective at eliciting a strong immune Th1 immune 
response as M1 macrophages (by design), and by themselves they have been implicated 
in several pathologies, the most prominent of which are allergy and asthma (Duffield, 
2003, Gordon, 2003)  
  
Fig. 8: Parasites, by activating receptors like the chitin receptor on macrophages, induce a Th2 differentation. Adapted 
from Akira, 2010 
One of the key discoveries in the current distinction between M1 and M2 
macrophages was the discovery that they metabolize the amino acid arginine differently. 
12 
 
Macrophages take up arginine from the surrounding environment by cationic amino acid 
transporters (cat) embedded in their plasma membrane (Schapria et al., 1998). Once taken 
into the cytosol, the cell has two basic options for metabolism of arginine – it can use the 
nitric oxide (NO) pathway, which is what happens if the cell is in the M1 phase, or the 
arginase pathway, used by M2 macrophages. These pathways produce different results – 
the NO pathway produces NO and L-cituline, while the arginase pathway produces urea 
and L-orthinine (Mills, 2001). This branching pathway, in which one phenotype 
metabolizes arginine through one pathway, and the other phenotype through another, 
generates a number of biological molecules which are unique to each pathway – thus 




Fig. 9: NOS2 and ARG1 are divergent, non-overlapping pathways of arginine metabolism.  Adapted from Bronte and 
Zanovello, 2005 
 
The NO pathway uses inducible nitric oxide synthease (iNOS) in the generation 
of nitric oxide. This pathway is upregulated by Th1 cytokines, especially IFN- γ and 
TNFα. Because of this, the NO pathway is also present in M1 or classically activated 
macrophages (Bogdan, 2001). iNOS is expressed constantly during the time a 
macrophage spends in the M1 phenotype, so massive amounts of NO can accumulate, up 
to 1000 times the levels of NO present in unstimulated, or M0 macrophages (Bogdan, 
2001). NO inhibits cell replication (Nathan et al, 1991) and inhibits mitochondrial 
respiration. NO also triggers apoptosis (Albina et al, 1993; Saio et. Al, 2001). 
Additionally, NO can interact with superoxide to create peroxynitrite. Superoxide is an 
oxygen radical also generated by macrophages. While in some cases superoxide can 
increase the cytotoxic effects of M1 macrophages, it may inhibit NO toxicity (Bautista 
and Spitzer, 1994), – an effect which can be reversed by the production of superoxide 




Fig. 10: The signaling pathway of iNOS releases toxic NO, and is mediated by Jak/Stat signaling. Adapted from 
Howard et al., 2010 
Instead of the NO pathway, M2 macrophages use the arginase pathway. While 
macrophages contain both arginase I and arginase II, arginase I is the enzyme used in the 
NO pathway. It is present in the cytosol (arginase II is present in the mitochondria). 
Arginase I (ARG1) expression is upregulated in response to Th2 cytokines: IL-4, IL-13, 
TFGβ, and IL-10 (Morris et. Al, 1998). Arginase I converts arginine to orthinine, which 
is then converted to polyamines. Polyamines are required for DNA replication, so their 
production favors cell proliferation (Pegg, 1988). This is part of the reason that the 
arginase pathway seems to favor tumor proliferation. The arginase pathway also favors 




Fig 11: As shown here, the Arginase pathway produces Orthinine as one of its products, which is a building block for 
polyamines, promoting cell growth and hence tumor proliferation. Adapted from Caldwell, 2010.  
These same properties also make the M2 macrophages ideal for tissue and nerve 
regrowth, and may help in wound healing after nerve damage (Kigerl, 2009). 
While the M1/M2 nomenclature will be used in the scope of this paper, it is 
important to note that there are certain shortcomings to the nomenclature. Some 
transcriptional studies (Biswas et al., 2006; Ghassabeh et al., 2002) have shown that some 
populations of macrophages are intermediates between the two phenotypes, and have 
transcriptional profiles that don’t match a simple definition as M1 or M2 macrophages – 
they have characteristics of each. It is not currently known if these macrophages represent 
other discrete phenotypes, or if there exists a gradient of M1-like and M2-like 
characteristics, which a macrophage might express many combinations of. One solution 
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to this problem taken by Mantovani et al. (2004), is to further divide M2 macrophages. In 
this system, M1 refers to macrophages which are activated by LPS, IFNgamma, and other 
Th1 type cytokines, and have the following profile: IL-10low, IL-12high, IL-23high, and 
are good antigen-presenting cells. They produce high levels of NO and other reactive 
oxygen intermediates. In contrast to this, the M2 category is a catchall for “not M1”, 
including macrophages that have a profile of IL-12low, IL-10high, with enhanced tissue 
remodeling properties. M2 macrophages are further divided into M2a and M2b. M2a 
macrophages are activated by IL-4 or IL-13, and M2b macrophages are activated by IL-
10 or glucocorticoid hormones (Mantovani et al., 2004). Future genomic and proteomic 
analysis may clarify the various phenotypic states that macrophages can exist in. For this 
paper, M1 indicates a more aggressive, proinflammatory, proliferative, pro-apoptosis 
phenotype, differentiated by the presence of iNOS, and M2 indicates an anti-
inflammatory, tissue regeneration-promoting phenotype differentiated by the expression 
of the arginase gene (Arg1). It is known that iNOS levels are very low in macrophages in 
the M2 phenotype, while Arg1 levels are very low in M1 macrophages. This is intuitively 
sensible, as these represent divergent paths in the metabolism of arginine, and are 
unlikely to coexist in large quantity. Macrophages that shift from an M1 phenotype to an 
M2a phenotype experience an increase in arginase expression that is concomitant with 
their reduction in inducible nitric oxide synthase (iNOS) expression (Munder et al., 1998, 




Figure 12: The NO produced by the M1 pathway (iNOS) leads to parasite killing, while the arginase 1 pathway shown 
in the middle leads to spermine and parasite proliferation. Adapted from Fouce et al., 2012 
Both the M1 and M2 populations of macrophages can be shown to have 
environments in which they are greatly helpful, and microenvironments in which their 
presence is either less helpful or actively harmful. M1 macrophages are important both in 
fighting infection and in the reduction and destruction of tumors. Because of their pro-
inflammatory, immune cell-recruiting cytokines, and because of their proliferation and 
activation of the rest of the immune system, M1 macrophages are associated with 
increased odds of survival during cancer, and in general anti-tumor activities (Ma et al., 
2010). Additionally, due to the anti-microbial properties of M1 macrophages, the 
common immunological response during acute infection (by bacteria or viruses, not 




Fig 13: IFN-gamma, TNF, LPS polarize towards the M1 phenotype, while parasites, specigically Chitin, or IL-4 
polarizes macrophages towards the M2 phenotype. Adapted from Satoh et al., 2010  
As an example, during infection with Listeria monocytogenes, which causes 
disease in pregnant women and the immunocompromised, the body  induces the M1 
phenotype in macrophages. The pro-phagocytic cytokines act to prevent bacterial 
phagosome escape. This allows for increased intracellular killing of bacteria both in vitro 
and in vivo (Shaughnessy and Swanson, 2007). Studies done using mice that do not have 
IFN-γ and TNF and their receptors (two markers of M1 polarization) die from L. 
monocytogenes infection (Pfeffer et al., 1993). Similarly, Salmonella typhi, the agent of 
typhoid fever, and Salmonella typhimurium, a gastroenteritis agent, induce the M1 
polarization of human and murine macrophages, and this induction is associated with the 
control of the infection (Benoit and Mege, 2008). 
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M2 macrophages show the most positive effects when mediating wound healing 
and nerve regrowth. M2 macrophages aid in tissue healing, nerve regrowth, and 
angiogenesis by releasing cytokines which promote angiogenesis and matrix remodeling 
while simultaneously suppressing destructive immunity (Sica et al., 2006). In one 
exploratory study, it was found that in mice who received an electromechanical contusion 
in their central nervous system (CNS), M2 macrophages promoted nerve regrowth with 
axons regrowing to more than two times the length of axons in tissues where M1 
macrophages predominated. It was hypothesized that, since the population of M1 
macrophages persists for far longer than the M2 population, which lasts about 3-7 days, 
M2 macrophages were responsible for wound healing and nerve re-growth in the 
damaged region, and M1 macrophages might protect the area from secondary infection. 
The authors suggested that understanding the diverse roles that M1 and M2 macrophages 
played in the course of CNS wound healing would be informative. They also suggested 
that the ability to modulate the phenotypic profiles of the macrophages involved in the 
wound after nerve damage might be highly valuable in producing more desirable 




Fig 14:Through upregulation of TNF-alpha and infiltration of macrophages into wound tissue, Keratinocyotes and 
Fibroplasts are stimulated through the TNFR1 and facilitate wound healing. Adapted from Lia et al., 2009 
The subject of macrophage polarization is a complex one, and not everything is 
known about the ways in which macrophages become polarized to one phenotype 
or another. Nonetheless, some generalizations can be drawn. It is known that 
macrophages become polarized to the M1, or classically activated phenotype, 
after stimulation with LPS or IFN-γ or both, which induces TNF-α, and M2 or 
alternatively activated macrophages were produced after stimulation with IL-4 
and IL-13 (Gordon, 2003). It is also known that LPS + IL-1β, IC + IL-1ra, TGFβ, 
and IL-10 can stimulate M2 macrophages (Martinez et al., 2008), and other 
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proinflammatory cytokines such as IFNs, IL-1, IL-2, and hypoxia can induce M1 
macrophages polarization. Obviously, then, there are a diverse set of pathways 
that can lead to their activation (Melillo, 1995, Kleinart et al., 2003)  
  
Fig. 15: In general, Th1 cytokines, LPS, and IFN-gamma stimulate the M1 phenotype, responsible for inflammation 
and further stimulation of the immune system, while Th2 cytokines stimulate the repair-centered M2. Adapted from  
Sica et al., 2006 
Furthermore, macrophage phenotype is plastic – macrophages can be polarized to 
the M2 phenotype from the M1 phenotype, vice versa, and will revert to an unpolarized 
M0 phenotype in the absence of stimulus to one or the other phenotype (Devaraj and 
Jialal, 2011, Mantovani et al, 2002). To convert one macrophage phenotype to the other 
simply requires that the macrophage be stimulated with the appropriate polarizing 
signals, and taken out of the environment which initially polarized it to the opposite 
phenotype (Kirgerl et al., 2009).  
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Because understanding macrophage polarization might give insight into disease 
progression and wound healing, because there are selectable markers that indicate the 
state of the macrophage phenotype (iNOS for M1, ARG1 for M2), and because all the 
current tests for macrophage phenotype rely on lengthy detection of proteins through 
immunological assay (i.e. ELISA tests, flow cytometry, western blots), it is desirable to 
develop a quantitative, real-time test for the state of the macrophage using the markers 
mentioned above, which can be performed on live cells.  
MATERIALS AND METHODS 
 The goal of this project is to create a macrophage cell line which allows 
visualization of macrophage polarity in real-time on live cells. This is to be done by the 
creation of a plasmid which detects transcription of proteins indicating one or the other 
phenotypic state, coupled to a reporter  
  




 The reporter for this system was to be either green or red fluorescent protein (GFP 
and RFP, respectively). GFP and RFP are relatively well-characterized molecules that 
fluoresce either a green or a red color when excited with a different UV light wavelength 
(Inouye and Tsuji, 1994). Their expression is non-toxic to cells, easily detected through 
non-lethal doses of UV radiation, and able to be quantified using a spectrophotometer 
(Chalfie et al., 1994).  
 In addition to the reporter system, a means of detecting the phenotypic state of 
macrophages is needed for this plasmid. As mentioned above, the levels of iNOS and 
ARG1 are inversely related, with iNOS being high and ARG low in M1 macrophages, 
and vice versa. This is because they play opposite roles in the metabolism of arginine, 
with the MO pathway being used in M1 macrophages, and the arginase pathway in M2. 
The promoter regions for the iNOS and ARG1 genes, therefore, will be used in the 
construction of the plasmid. Fortunately, botch of these promoters have previously been 





Fig 17, the Arg1 promoter plasmid – note the firefly luciferase for identification, and the MhuI and XhoI sites for 
restriction digests. Adapted from Pauleau, 2004 
who found that both the promoter region and an enhancer ~kb upstream from the 
promoter start site were required in a plasmid for stable and significant activation when 
the host cell promotes ARG1 transcription. The iNOS plasmid was found to be sufficient 
without enhancer regions to be activated on a plasmid when the host cell activated iNOS 




Fig 18: The iNOS promoter plasmid also includes an upstream enhancer region. Adapted from Andresen et al., 2004.  
Both plasmids were graciously provided by the respective labs that developed them. 
 Once the plasmids were obtained, a vector and E. coli line were chosen. This 
project will use the pBluescript SK+ plasmid vector (PBSSK+) for bacterial expression, 
both for its stable expression in a variety of bacteria, and also for its MCS, which 
contains the appropriate restriction sites. The PBSSK+ plasmid is capable of holding both 
the ARG1 and iNOS promoter. Appropriate cloning sites must be chosen – ideal sites 
should be found on either end of the promoter section of the promoter plasmid and on the 
MCS of the pBSSK+ plasmid for proper insertion of the promoter into the bacterial 
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expression vector. Additionally, an appropriate host strain of E. coli must be selected. 
Stbl3 E. coli were chosen for this project, because they proved able to uptake the plasmid 
and were able to be grown on a miniprep afterwards.  
 
Following selection of restriction sites, and E. coli population, a concentration of 
the appropriate promoter plasmid is transfected into the stbl3 E. coli. This is grown in 
culture overnight. The culture is isolated, and the plasmid DNA is isolated through a 
miniprep. This DNA is subjected to a restriction digest with the predetermined restriction 
enzymes, which are then run in an electrophoresis gel. Assuming the correct size bands 
are found, which indicates a successful restriction digest, the E. coli is grown up and the 
plasmid DNA isolated in a maxiprep (which gives much greater plasmid yield as 
compared to the miniprep). 
FUTURE WORK 
 
After growing the E. coli and harvesting the plasmid DNA in a maxiprep, the DNA is 
then run again on a gel. Assuming the correct size bands are found, the DNA will be 
isolated from the gel and added to a solution of PBSSK+ plasmid which will be cut with 
the appropriate restriction enzymes to encourage uptake on plasmid, along with ligase. 
This ligation mix will be incubated, and added to a culture of E. coli which will be 
subjected to heat shock. If successful, this procedure will introduce the PBSSK+  
promoter into the culture of E. coli. This will yield a plasmid which confers bacterial 
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ampicillin resistance to the E. coli, and will become activated along with the appropriate 
protein (iNOS or ARG1) because of the promoter element. The procedure to insert the 
promoter section into the plasmid will then be repeated to add GFP or RFP to the 5’ end 
of the promoter plasmid on the plasmid, meaning that activation of the promoter element 
on the plasmid will yield GFP or RFP.  
 
Fig. 19: The final shape of the PBSSK+ plasmid 
Meanwhile, a culture of the macrophages (in this case, RAW 277.97 
macrophages) are transfected with a PBSSK+ plasmid with the GFP or RFP sequences to 
be used in the experiment attached to a constitutive promoter, and one with GFP and RFP 
with no attached promoter. These macrophages are examined under a fluorescent 
microscope, and used as baselines for total expression and non-expression of the marker. 
These endpoints will be used to evaluate the strength of the expression of the GFP and 
RFP in the plasmid with the promoter element. The E. coli transformed with the promoter 
plasmid + GFP or RFP are selected by growing on amp+ media. These E. coli are grown 
28 
 
overnight in amp+ broth followed by a miniprep experiment to determine that the 
plasmid has been inserted correctly, in the proper orientation in the E. coli. These 
plasmids containing the promoter of interest and either GFP or RFP are then transfected 
into the macrophage cell line with lipofectamine, which increases the efficiency of 
transfection.  This yields the cell line of interest – a culture of macrophages that will 
fluoresce green or red when the iNOS or ARG1 is promoted in culture. Next, the 
macrophages which have successfully taken up the plasmid must be isolated and cloned. 
This involves isolating macrophages that fluoresce under appropriate UV radiation, and 
clonally growing them. The copy number of the plasmids in these macrophages must now 
be determined. This can be performed by Southern blot, by comparing the signal intensity 
of the unknown copy number to a known copy number. This process should then be 
repeated using the other promoter/reporter, transforming the promoter + reporter into the 
macrophages that already contain one such construct. The final macrophage will express 
GFP if one promoter is activated, and RFP if another is activated. This plasmid system is 
then tested by incubating these macrophages with cytokines known to polarize the 
macrophage to one phenotype or another (LPS and IFN-γ for M1, IL-4 and IL-10 for 







POSSIBLE PROBLEMS/SOLUTIONS  
 
There are a few foreseeable problems that could arise during the construction of 
these transgenic macrophages. First, and most potentially troublesome, is the difficulty of 
cloning the macrophages after isolation based on GFP expression. Macrophages can be 
difficult to cultivate following isolation, as individual macrophage cells frequently have 
trouble expanding, and die, even in media with sufficient nutrients. This could be solved, 
if necessary, by using a macrophage line which has been shown to be able to clonally 
expand after the uptake of a transgene, such as mouse alveolar macrophages (Joshi et al., 
2008). Additionally, the reporters might have to be altered. There is some spectral 
overlap between the range of UV wavelengths that GFP and RFP respond to, and there 
could potentially be confusion in interpreting fluorescence. If this is a problem, markers 




Once the system is in place, the macrophages can be given any number of 
challenges – infection with foreign agents, bacterial or viral, addition of cytokines whose 
polarizing effects on macrophages are unknown, polarization profiles after being affected 
by a number of different cytokines. Of initial interest would be visualizing the 
polarization of macrophages in the presence of herpes simplex virus – it is possible that 
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due to their persistence in cells long-term, they might act to induce an M2 polarization of 
macrophages. Likewise, both acute and long-term bacterial infectious agents could be 
investigated, to see if different ones induce different polarization profiles in 
macrophages. It would also be interesting to see if different classes of infectious agents – 
bacteria, viruses, and parasites, tend to induce different profiles, especially because 
parasites are mostly greatly affected by th2 mechanisms, it would be interesting to see if 
M2 macrophages predominate, and over what time periods they predominate, in parasitic 
infection.  
The real-time nature of the expression of GFP and RFP means that the time a cell 
remains polarized, and the speed with which it becomes depolarized, could be explored in 
much greater detail than has yet been observed. Additionally, using this system as a 
model, promoters for other proteins of interest during macrophage polarization could be 
detected using expression of GFP and RFP, as an example, the SOCS pathway could be 
investigated in some detail. It is also possible that the polarization of macrophages in 
vivo could be investigated. In this situation, promonocytes could be isolated from murine 
bone marrow, and transformed with the promoter/reporter system described above. If re-
introduced into the mouse they were taken from, these cells could produce macrophages 
which expressed the promoter/reporter construct. While GFP/RFP would be inappropriate 
for this task, noninvasive bioluminescent imaging with luciferase has been shown to be 
able to image selected cells in whole animals. This could show real-time images of the 
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progression of macrophage polarization in whole animals during the course of injury or 
infection (Mezzanotte et al., 2011). 
The use plasmids to solve other biological problem is expanding on multiple 
fronts. One other possibility for recombinant DNA is the construction of computational 
plasmids. In computational plasmids, assume that P is a plasmid, k is a positive integer 
and s1 to sk are k pairwise non-overlapping subsegments of P. Also assume that for each 
i, the nucleotide sequence of si is unique within the plasmid P. These unique segments 
chosen in this way are ‘stations’ of the plasmid. Once this setup is developed, a 
computation is begun. It begins with a test tube of or buffer that contains many identical 
k-station plasmids. The plasmids are modified in such a way as to be readable later, and 
only modified at the stations. Because of this binary modification, each station on the 
plasmid is either modified or unmodified, which can be thought of as one of the bits – a 1 
or a 0 
 
Fig. 20: By dividing the strand of DNA into “stations” with specific restriction enzymes, operations can be performed 
independently on separate stations and the final results can be computed by examining stations later. Adapted from 
Head et al., 2000. 
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When conceived of in this way, each station is similar to a k-bit data register in a 
computer. The “memory” in this kind of computing is simply the totality of the system – 
the water plus the plasmid content. This is done because water helps with rapid 
partitioning of memory into subsets. This can be accomplished through stirring or 
diffusion. It makes the assumption that each of the members of such a partition contains 
the same variety of molecules. Different, separate members of the partition can be 
modified in different ways and brought back later into a single test tube. Once brought 
back together, the final “solution”, or computational answer, is read from the solution – 
the water plus plasmid. Many separate methods for modifying the plasmid might exist, 
but cutting and pasting sequences is a valid way to modify them. In this way, the speed 
and accuracy of biological processes can be brought to bear to solve complex 
mathematical problems (Head et al., 2000). 
 Another problem that can be solved with plasmids, in this case larger-scale ones, 
is to create a DNA library. In a DNA library, a collection of DNA fragments that come 
from one organism, and are stored in another, often a bacterium, are collected. This is 
first achieved by extracting and purifying DNA from human cells. This collected DNA is 
likely made of extremely long strands of DNA, so it is digested with restriction enzymes. 
Because DNA is so large, each restriction enzyme is likely to cut the DNA in multiple 
places. Thousands of fragments are thus generated, each of which might contain one or 
more genes. Each fragment is then inserted into a plasmid vector – this can be done 
because researchers know the profile of restriction enzymes they used to create the 
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fragments, thus they know the profiles of the sticky ends of the pieces of DNA, and can 
cut plasmid vectors with the matching restriction enzymes. The fragments are then put 
into E. coli, which is grown to large numbers, creating many copies of each fragment of 
DNA 
 
Fig 21. Construction of a plasmid-based DNA library involves cutting the DNA from a cell into piecies, ligating them 
into the vector, and storing the vector in bacteria – the process is similar for a cDNA library, but mRNA is converted 
through reverse transcriptase into cDNA which is then inserted into the vectors. Adapted from Winning, 2012. 
The fragments of DNA can then be isolated and studied, or the researcher can further 
isolate the particular genes they are interested in for further study. (Cain et al., 2006) 
 There has been a great amount of interest lately in recombinant DNA and 
molecular biology – one source for models of molecular and sensing biology is the 
international genetically engineered machine (iGem) competition. This competition, for 
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undergraduate biology students, involves being a standard set of biological building 
blocks (standardized plasmids, promoters, reporting systems, etc.) taken from the registry 
of standard biological parts. These parts are combined to create biological models that 
accomplish creative and useful tasks (igem.org). part of the inspiration for this project 
was taken from a project in which E. coli was modified to detect environmental mercury 
through production of GFP. This was accomplished through a plasmid that detected 
changes in the host cell commonly associated with the cell responding to environmental 
mercury, and designed a plasmid that would express green fluorescent protein when this 
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